Polycystic ovary syndrome;Le syndrome des ovaires polymicrokystiques

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 29, Issue 3, 2000, Pages 298-301

  Dewailly, D ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b NONE   (France)

Author keywords

Hyperandrogenism pathogeny; Polycystic ovary; Treatment

Indexed keywords

CYPROTERONE ACETATE; FOLLITROPIN; GONADORELIN; LUTEINIZING HORMONE;

ANOVULATION; CLINICAL FEATURE; CONFERENCE PAPER; ECHOGRAPHY; FEMALE; HUMAN; HYPERANDROGENISM; HYPERINSULINISM; MENSTRUAL CYCLE; OVARY DISEASE; OVARY POLYCYSTIC DISEASE;

EID: 0034027749     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Dewailly D. Definition and Significance of Polycystic Ovaries. In Hyperandrogenic States and Hirsutism. Rosenfield RL, Ed. Balliere's Clinical Obstetrics and Gynaecology 1997; vol 11 (2), pp 349-68.
2. Donesky BW, Adashi EY. Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy. Fertil Steril 1995; 63: 439-63.
3. Dunaif A. Molecular mechanisms of insulin resistance in PCOS. In Androgen Excess Disorders in Women. Azziz R, Nestler JE and Dewailly D, eds. Lippincott-Raven Publishers, Philadelphia, 1997, pp 485-96.
4. Geller DH, Auchus RJ, Miller WL. The role of P450c17 in adrogen biosynthesis. In Androgen Excess Disorders in Women. Azziz R, Nestler JE and Dewailly D, eds. Lippincott-Raven Publishers, Philadelphia, 1997, pp 315-25.
5. Hughesdon PE. Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called "hyperthecosis". Obstet Gynecol Surv 1982; 37: 59-77.
6. Messinis IE, Milingos SD. Current and future status of ovulation induction in polycystic ovary syndrome. Human Reproduction Update 1997; 3: 235-53.
7. Pigny P, Desailloud R, Cortet-Rudelli C, Duhamel A, Deroubaix-Allard D, Racadot A, Dewailly D. Serum α-inhibin levels in Polycystic Ovary Syndrome: Relationship to serum androstenedione level. J Clin Endocrinol Metab 1997; 82: 1939-43.
8. Urbanek M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA, Norman RJ, Strauss JF, Spielman RS, Dunaif A. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Natl Acad Sci USA 1999; 96: 8573-8
9. WilliS DS, Watson H, Mason HD, Galea R, Brincat M, Franks S. Premature response to luteinizing hormone of granulosa cells from anovulatory women with polycystic ovary syndrome: relevance to mechanism of anovulation. J Clin Endocrinol Metab 1998; 83: 3984-91.
10. Wyne KL, Bradshaw KD. Treatment of insulin resistance in polycystic ovary syndrome. Curr Op Endocrinol Diab 1998; 5: 321-9.